These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7946943)
1. Colchicine concentration in leukocytes of patients with familial Mediterranean fever. Chappey O; Niel E; Dervichian M; Wautier JL; Scherrmann JM; Cattan D Br J Clin Pharmacol; 1994 Jul; 38(1):87-9. PubMed ID: 7946943 [TBL] [Abstract][Full Text] [Related]
2. Colchicine disposition in human leukocytes after single and multiple oral administration. Chappey ON; Niel E; Wautier JL; Hung PP; Dervichian M; Cattan D; Scherrmann JM Clin Pharmacol Ther; 1993 Oct; 54(4):360-7. PubMed ID: 8222477 [TBL] [Abstract][Full Text] [Related]
3. Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis. Katz EZ; Ehrenfeld M; Levy M; Eliakim M Arthritis Rheum; 1982 Feb; 25(2):227-31. PubMed ID: 7066054 [No Abstract] [Full Text] [Related]
4. Colchicine treatment in familial Mediterranean fever: an indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors. Barash J; Pirogovski A; Livneh A; Brezniak N; Dror Y; Hahn T Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S76. PubMed ID: 11760407 [No Abstract] [Full Text] [Related]
5. Colchicine in breast milk of patients with familial Mediterranean fever. Ben-Chetrit E; Scherrmann JM; Levy M Arthritis Rheum; 1996 Jul; 39(7):1213-7. PubMed ID: 8670333 [TBL] [Abstract][Full Text] [Related]
6. Colchicine kinetics in patients with familial Mediterranean fever. Halkin H; Dany S; Greenwald M; Shnaps Y; Tirosh M Clin Pharmacol Ther; 1980 Jul; 28(1):82-7. PubMed ID: 7389258 [TBL] [Abstract][Full Text] [Related]
7. The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2. Levy M; Eldor A; Zylber-Katz E; Eliakim M Br J Clin Pharmacol; 1983 Aug; 16(2):191-4. PubMed ID: 6615693 [TBL] [Abstract][Full Text] [Related]
8. Colchicine disposition in patients with familial Mediterranean fever with renal impairment. Ben-Chetrit E; Scherrmann JM; Zylber-Katz E; Levy M J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398 [TBL] [Abstract][Full Text] [Related]
9. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Bar-Eli M; Ehrenfeld M; Levy M; Gallily R; Eliakim M Am J Med Sci; 1981; 281(1):15-8. PubMed ID: 7468635 [TBL] [Abstract][Full Text] [Related]
10. Colchicine in tear fluid of treated patients with familial Mediterranean fever. Leibovitch I; Alster Y; Scherrmann JM; Azmon B; Barequet IS; Livneh A; O'Brien TP; Lazar M; Loewenstein A Cornea; 2003 Apr; 22(3):191-3. PubMed ID: 12658080 [TBL] [Abstract][Full Text] [Related]
11. Interventions for reducing inflammation in familial Mediterranean fever. Wu B; Xu T; Li Y; Yin X Cochrane Database Syst Rev; 2015 Mar; (3):CD010893. PubMed ID: 25791871 [TBL] [Abstract][Full Text] [Related]
12. Plasma dopamine beta-hydroxylase activity in familial Mediterranean fever. Courillon-Mallet A; Cauet N; Dervichian M; Launay JM; Cattan D Isr J Med Sci; 1992 Jul; 28(7):427-9. PubMed ID: 1506166 [No Abstract] [Full Text] [Related]